Ten63 Therapeutics: Valuation, Funding & Investors
Ten63 Therapeutics develops AI-driven drug discovery technologies focused on accelerating small-molecule discovery through advanced computational platforms. The company’s BEYOND platform simulates trillions of potential drug candidates per protein and aims to enable affordable small-molecule therapies against previously undruggable viral targets, including efforts to address the global HPV pandemic.
Leadership & Board
- Current Number of Employees
- 33
- Current LinkedIn Followers
- 5,575
Latest Estimated Valuation
- Total Amount Raised
- $45M
- Total Funding Rounds
- 1
- Latest Funding Amount
- $45M
- Latest Funding Round
- Investment
Employee Trend
Ten63 Therapeutics had 33 employees as of November 2, 2026. The number of employees increased by 0 (0.00%) week-over-week.
Social Trend
Ten63 Therapeutics had 5,575 followers as of November 2, 2026. The number of followers increased by 46 (0.83%) week-over-week.
Funding Round
| Funding Date | Funding Round | Amount Raised | Post-Money Valuation |
|---|---|---|---|
| Feb 19, 2026 | Investment | $45.00M | ― |
Investors
| Investor Name | Funding Round |
|---|---|
| Chugai Venture Fund | Investment |
| Gates Foundation | Investment |
Similar Companies
A snapshot of private companies similar to Ten63 Therapeutics, helping you discover and navigate related company profiles.
